Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serum Amyloid A Protein | 21 | 2024 | 44 | 4.220 |
Why?
|
| Lipoproteins, HDL | 16 | 2021 | 117 | 3.800 |
Why?
|
| Group X Phospholipases A2 | 6 | 2016 | 8 | 1.950 |
Why?
|
| Apolipoproteins E | 10 | 2024 | 204 | 1.700 |
Why?
|
| Group V Phospholipases A2 | 5 | 2017 | 5 | 1.400 |
Why?
|
| Atherosclerosis | 12 | 2023 | 999 | 1.390 |
Why?
|
| Aortic Aneurysm, Abdominal | 6 | 2024 | 445 | 1.220 |
Why?
|
| Angiotensin II | 5 | 2024 | 168 | 1.220 |
Why?
|
| Phospholipases A | 5 | 2007 | 39 | 1.180 |
Why?
|
| Lipoproteins, LDL | 7 | 2013 | 137 | 1.160 |
Why?
|
| Mice, Inbred C57BL | 28 | 2024 | 4841 | 1.040 |
Why?
|
| Hepatocytes | 6 | 2020 | 241 | 1.020 |
Why?
|
| Inflammation | 8 | 2022 | 1591 | 1.010 |
Why?
|
| Insulin-Secreting Cells | 2 | 2017 | 150 | 0.900 |
Why?
|
| Adrenal Glands | 2 | 2015 | 54 | 0.790 |
Why?
|
| Cholesterol | 9 | 2022 | 573 | 0.780 |
Why?
|
| Phospholipases A2, Secretory | 2 | 2015 | 4 | 0.780 |
Why?
|
| Mice, Knockout | 17 | 2024 | 3991 | 0.770 |
Why?
|
| Acute-Phase Reaction | 4 | 2017 | 14 | 0.760 |
Why?
|
| Mice | 35 | 2024 | 18948 | 0.750 |
Why?
|
| Receptors, LDL | 3 | 2009 | 102 | 0.750 |
Why?
|
| CD36 Antigens | 3 | 2007 | 42 | 0.710 |
Why?
|
| Macrophages | 9 | 2018 | 703 | 0.700 |
Why?
|
| Apolipoprotein A-I | 9 | 2020 | 89 | 0.690 |
Why?
|
| Animals | 46 | 2024 | 36421 | 0.690 |
Why?
|
| Scavenger Receptors, Class B | 6 | 2016 | 12 | 0.580 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 126 | 0.540 |
Why?
|
| Aortic Diseases | 4 | 2020 | 203 | 0.530 |
Why?
|
| Aorta | 5 | 2023 | 559 | 0.520 |
Why?
|
| Lipoproteins | 5 | 2011 | 192 | 0.520 |
Why?
|
| Inflammasomes | 1 | 2018 | 167 | 0.510 |
Why?
|
| Furin | 1 | 2015 | 9 | 0.470 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 526 | 0.470 |
Why?
|
| Proprotein Convertases | 1 | 2015 | 27 | 0.470 |
Why?
|
| Arteriosclerosis | 3 | 2005 | 149 | 0.460 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2015 | 97 | 0.460 |
Why?
|
| ATP-Binding Cassette Transporters | 4 | 2015 | 197 | 0.450 |
Why?
|
| Cyclooxygenase 2 | 1 | 2014 | 143 | 0.430 |
Why?
|
| Cholesterol, HDL | 3 | 2016 | 395 | 0.430 |
Why?
|
| Steroids | 1 | 2015 | 213 | 0.420 |
Why?
|
| Insulin | 2 | 2017 | 1258 | 0.400 |
Why?
|
| Proteoglycans | 4 | 2018 | 94 | 0.370 |
Why?
|
| Lipase | 1 | 2011 | 98 | 0.360 |
Why?
|
| Macrophages, Peritoneal | 3 | 2009 | 41 | 0.330 |
Why?
|
| Group II Phospholipases A2 | 5 | 2016 | 9 | 0.320 |
Why?
|
| Adipogenesis | 1 | 2010 | 79 | 0.320 |
Why?
|
| Foam Cells | 2 | 2009 | 24 | 0.320 |
Why?
|
| Extracellular Matrix | 3 | 2020 | 250 | 0.310 |
Why?
|
| Endocytosis | 2 | 2007 | 133 | 0.310 |
Why?
|
| Phosphoproteins | 2 | 2016 | 456 | 0.310 |
Why?
|
| Liver | 4 | 2021 | 1878 | 0.300 |
Why?
|
| Apolipoproteins B | 2 | 2013 | 145 | 0.290 |
Why?
|
| Down-Regulation | 1 | 2010 | 716 | 0.280 |
Why?
|
| Disease Models, Animal | 11 | 2024 | 4793 | 0.280 |
Why?
|
| Dinoprostone | 3 | 2017 | 82 | 0.270 |
Why?
|
| COS Cells | 4 | 2011 | 283 | 0.270 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 2655 | 0.270 |
Why?
|
| Cells, Cultured | 8 | 2017 | 3173 | 0.270 |
Why?
|
| Cell Line | 4 | 2017 | 2841 | 0.270 |
Why?
|
| Aortic Aneurysm | 2 | 2020 | 234 | 0.270 |
Why?
|
| Myocardium | 1 | 2012 | 1045 | 0.270 |
Why?
|
| Cholesterol Ester Transfer Proteins | 3 | 2023 | 42 | 0.260 |
Why?
|
| Disease Progression | 1 | 2012 | 2239 | 0.250 |
Why?
|
| Immunity, Innate | 1 | 2008 | 416 | 0.240 |
Why?
|
| Islets of Langerhans | 2 | 2017 | 178 | 0.230 |
Why?
|
| Phospholipases A2 | 4 | 2007 | 38 | 0.230 |
Why?
|
| Arachidonic Acid | 2 | 2017 | 83 | 0.220 |
Why?
|
| Fibroblasts | 2 | 2020 | 921 | 0.210 |
Why?
|
| Receptors, Lipoprotein | 1 | 2002 | 11 | 0.200 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2015 | 81 | 0.200 |
Why?
|
| Adenoviridae | 3 | 2014 | 610 | 0.200 |
Why?
|
| Sucrose | 1 | 2022 | 43 | 0.190 |
Why?
|
| Lung Injury | 1 | 2023 | 123 | 0.190 |
Why?
|
| ATP Binding Cassette Transporter 1 | 5 | 2015 | 22 | 0.190 |
Why?
|
| Hydrolysis | 3 | 2009 | 164 | 0.190 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 126 | 0.190 |
Why?
|
| Mice, Transgenic | 5 | 2014 | 2529 | 0.180 |
Why?
|
| Humans | 29 | 2024 | 133705 | 0.180 |
Why?
|
| Cardiovascular Diseases | 2 | 2014 | 2090 | 0.180 |
Why?
|
| Glucose | 2 | 2017 | 925 | 0.180 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 1762 | 0.180 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2010 | 21 | 0.170 |
Why?
|
| Liver X Receptors | 2 | 2010 | 19 | 0.170 |
Why?
|
| Luciferases | 2 | 2010 | 137 | 0.170 |
Why?
|
| Male | 17 | 2024 | 65850 | 0.160 |
Why?
|
| Lipid Metabolism | 4 | 2007 | 383 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2020 | 4908 | 0.160 |
Why?
|
| Aorta, Abdominal | 3 | 2024 | 125 | 0.160 |
Why?
|
| Collagen | 2 | 2012 | 327 | 0.160 |
Why?
|
| Sepsis | 1 | 2023 | 519 | 0.150 |
Why?
|
| Membrane Proteins | 2 | 2007 | 1604 | 0.150 |
Why?
|
| Cathepsin B | 1 | 2018 | 12 | 0.150 |
Why?
|
| Biological Transport | 3 | 2009 | 369 | 0.150 |
Why?
|
| Apolipoproteins | 1 | 2018 | 72 | 0.150 |
Why?
|
| Caspase 1 | 1 | 2018 | 45 | 0.150 |
Why?
|
| Research Personnel | 1 | 2020 | 135 | 0.150 |
Why?
|
| Base Sequence | 2 | 2015 | 3172 | 0.150 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2017 | 13 | 0.140 |
Why?
|
| Lipopolysaccharides | 2 | 2017 | 320 | 0.140 |
Why?
|
| American Heart Association | 1 | 2020 | 329 | 0.140 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 167 | 0.140 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 226 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 2165 | 0.130 |
Why?
|
| Cholesterol Esters | 2 | 2006 | 16 | 0.130 |
Why?
|
| Intestinal Neoplasms | 1 | 2016 | 41 | 0.120 |
Why?
|
| Stem Cell Niche | 1 | 2016 | 58 | 0.120 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 745 | 0.120 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 154 | 0.120 |
Why?
|
| Transfection | 2 | 2010 | 1090 | 0.120 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 936 | 0.120 |
Why?
|
| Particle Size | 2 | 2013 | 148 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 1327 | 0.120 |
Why?
|
| Peripheral Arterial Disease | 1 | 2020 | 313 | 0.120 |
Why?
|
| HEK293 Cells | 1 | 2018 | 814 | 0.120 |
Why?
|
| Elastin | 1 | 2015 | 31 | 0.120 |
Why?
|
| Protein Isoforms | 1 | 2016 | 429 | 0.110 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2014 | 17 | 0.110 |
Why?
|
| Apolipoprotein A-II | 3 | 2016 | 8 | 0.110 |
Why?
|
| Biomarkers | 2 | 2015 | 3430 | 0.110 |
Why?
|
| Dietary Fats | 2 | 2009 | 299 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2006 | 366 | 0.110 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 690 | 0.110 |
Why?
|
| Crosses, Genetic | 2 | 2005 | 170 | 0.110 |
Why?
|
| Random Allocation | 1 | 2015 | 448 | 0.110 |
Why?
|
| Proteolysis | 1 | 2015 | 196 | 0.110 |
Why?
|
| DNA Primers | 1 | 2015 | 669 | 0.110 |
Why?
|
| Validation Studies as Topic | 1 | 2013 | 14 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2020 | 556 | 0.110 |
Why?
|
| Enzyme Activation | 1 | 2015 | 645 | 0.100 |
Why?
|
| Blood Chemical Analysis | 1 | 2013 | 88 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2013 | 136 | 0.100 |
Why?
|
| Adiposity | 2 | 2013 | 206 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 732 | 0.100 |
Why?
|
| NADPH Oxidase 4 | 1 | 2012 | 14 | 0.100 |
Why?
|
| Hypertension | 1 | 2021 | 1397 | 0.100 |
Why?
|
| NADPH Oxidase 2 | 1 | 2012 | 41 | 0.100 |
Why?
|
| Prostaglandins | 1 | 2012 | 48 | 0.100 |
Why?
|
| Gene Expression | 2 | 2010 | 1616 | 0.100 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 612 | 0.090 |
Why?
|
| Intestines | 1 | 2016 | 615 | 0.090 |
Why?
|
| Forecasting | 1 | 2013 | 376 | 0.090 |
Why?
|
| NADPH Oxidases | 1 | 2012 | 114 | 0.090 |
Why?
|
| Homeostasis | 1 | 2016 | 746 | 0.090 |
Why?
|
| Time Factors | 5 | 2013 | 6585 | 0.090 |
Why?
|
| Models, Animal | 1 | 2013 | 483 | 0.090 |
Why?
|
| Triglycerides | 2 | 2013 | 614 | 0.090 |
Why?
|
| Risk | 1 | 2013 | 834 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 1624 | 0.090 |
Why?
|
| Aortic Rupture | 1 | 2012 | 121 | 0.090 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2010 | 5 | 0.090 |
Why?
|
| Anticholesteremic Agents | 1 | 2013 | 245 | 0.090 |
Why?
|
| Biological Transport, Active | 1 | 2010 | 89 | 0.090 |
Why?
|
| Metalloproteases | 1 | 2010 | 15 | 0.090 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2010 | 77 | 0.090 |
Why?
|
| Fibrosis | 1 | 2012 | 462 | 0.080 |
Why?
|
| Corticosterone | 1 | 2010 | 63 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 432 | 0.080 |
Why?
|
| Lipids | 1 | 2013 | 566 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2554 | 0.080 |
Why?
|
| Obesity | 4 | 2024 | 2431 | 0.080 |
Why?
|
| Interleukins | 1 | 2010 | 130 | 0.080 |
Why?
|
| Female | 9 | 2022 | 71603 | 0.080 |
Why?
|
| Sphingomyelins | 1 | 2009 | 15 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 992 | 0.080 |
Why?
|
| Phosphatidylcholines | 1 | 2009 | 39 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1154 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2010 | 286 | 0.070 |
Why?
|
| Mice, Knockout, ApoE | 2 | 2018 | 5 | 0.070 |
Why?
|
| Genetic Vectors | 3 | 2014 | 970 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 714 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1410 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 3 | 2020 | 484 | 0.070 |
Why?
|
| Protein Binding | 2 | 2018 | 1844 | 0.070 |
Why?
|
| Caveolae | 1 | 2007 | 9 | 0.070 |
Why?
|
| Transferrin | 1 | 2007 | 50 | 0.070 |
Why?
|
| Dynamins | 1 | 2007 | 43 | 0.070 |
Why?
|
| Progesterone | 1 | 2010 | 634 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 232 | 0.070 |
Why?
|
| Ligands | 1 | 2008 | 572 | 0.070 |
Why?
|
| Microtubules | 1 | 2007 | 131 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 802 | 0.070 |
Why?
|
| Biotinylation | 1 | 2006 | 23 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2007 | 303 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 3032 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 336 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 1418 | 0.060 |
Why?
|
| Azo Compounds | 1 | 2005 | 11 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2006 | 231 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 471 | 0.060 |
Why?
|
| Lysosomes | 1 | 2007 | 262 | 0.060 |
Why?
|
| Hydrazines | 1 | 2005 | 34 | 0.060 |
Why?
|
| Peritoneum | 1 | 2005 | 40 | 0.060 |
Why?
|
| Reference Values | 1 | 2007 | 742 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2005 | 78 | 0.060 |
Why?
|
| Apoptosis | 1 | 2012 | 1928 | 0.060 |
Why?
|
| Actins | 1 | 2007 | 350 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2010 | 1420 | 0.060 |
Why?
|
| Cytokines | 2 | 2013 | 1396 | 0.060 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 270 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2020 | 178 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2898 | 0.050 |
Why?
|
| Heparin | 1 | 2005 | 225 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2020 | 248 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 366 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2024 | 89 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2004 | 313 | 0.050 |
Why?
|
| Chemokines | 1 | 2023 | 138 | 0.050 |
Why?
|
| Diet, Atherogenic | 1 | 2003 | 16 | 0.050 |
Why?
|
| Receptors, Scavenger | 1 | 2002 | 3 | 0.050 |
Why?
|
| Metabolic Clearance Rate | 1 | 2002 | 145 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2003 | 317 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2022 | 74 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2022 | 68 | 0.050 |
Why?
|
| Mutation | 2 | 2020 | 6294 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2005 | 1144 | 0.050 |
Why?
|
| Doxycycline | 1 | 2022 | 121 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 273 | 0.040 |
Why?
|
| Adipocytes | 1 | 2022 | 166 | 0.040 |
Why?
|
| Rats | 1 | 2007 | 3882 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2022 | 237 | 0.040 |
Why?
|
| Receptors, Angiotensin | 1 | 2020 | 21 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 226 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2020 | 92 | 0.040 |
Why?
|
| Vascular Remodeling | 1 | 2020 | 53 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2003 | 619 | 0.040 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2008 | 1159 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2020 | 65 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2789 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2020 | 158 | 0.040 |
Why?
|
| Apolipoprotein B-100 | 1 | 2018 | 39 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 3971 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3754 | 0.040 |
Why?
|
| Postprandial Period | 1 | 2018 | 91 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 149 | 0.040 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2019 | 165 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 230 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2019 | 450 | 0.030 |
Why?
|
| Paneth Cells | 1 | 2016 | 26 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2016 | 51 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 544 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1558 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2020 | 872 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 206 | 0.030 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 365 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2016 | 369 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2015 | 206 | 0.030 |
Why?
|
| Phospholipids | 1 | 2014 | 113 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2173 | 0.030 |
Why?
|
| Organoids | 1 | 2016 | 299 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 650 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 624 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 1707 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 259 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 704 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 326 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 204 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 584 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2013 | 236 | 0.020 |
Why?
|
| Stem Cells | 1 | 2016 | 752 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2013 | 503 | 0.020 |
Why?
|
| Smoking | 1 | 2015 | 1136 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 542 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 1134 | 0.020 |
Why?
|
| Receptors, Lipoxin | 1 | 2008 | 2 | 0.020 |
Why?
|
| Biglycan | 1 | 2008 | 7 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2008 | 71 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 538 | 0.020 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2008 | 6 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2008 | 35 | 0.020 |
Why?
|
| Haplorhini | 1 | 2008 | 121 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2016 | 2025 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 161 | 0.020 |
Why?
|
| Kidney | 1 | 2014 | 1418 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 11112 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 311 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 1439 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2005 | 130 | 0.010 |
Why?
|
| United States | 1 | 2020 | 11709 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2005 | 538 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 21674 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 29293 | 0.010 |
Why?
|